ASIC approves C3 name change

By Dylan Bushell-Embling
Tuesday, 17 June, 2008

The Australian Securities and Investments Commission (ASIC) has approved the request by Clinical Cell Culture (ASX: CCE) to rename itself Avita Medical.

The name change will take effect on June 26, when Avita will begin trading on the ASX under the code AVH.

Indigenous-led initiative to resurrect the South Island Giant Moa

New Zealand's Ngāi Tahu Research Centre has partnered with Colossal Biosciences and Sir Peter...

Abnormal brain protein targeted in Parkinson's study

Researchers have identified a new brain protein involved in the development of Parkinson's...

Epilepsy disease model treated in a laboratory dish

A research team has used an epilepsy-like disease model in a laboratory dish to demonstrate that...

Content from other channels on our network

A sustainable approach to increase wastewater recycling

NSW Govt supports business to use energy-saving heat pumps

Sustainability commitment key for LAPP Australia MD

City of Gosnells develops tree production nursery

Experts warn against health risks of plastic pollution

LAPP Australia launches Harnessing Solutions division

SA small and medium-sized businesses offered a new round of energy grants

Suntory Oceania's $3bn beverage business launched in Qld

Bega Group to close peanut processing business

Konica Minolta and MiR launching two autonomous robots at CeMat

New GDM diagnosis recommendations welcomed

Denise Lyons is the new APNA President

Regulators step in as medicinal cannabis prescriptions soar

Healthcare provider harnesses potential of agentic automation

2025 HESTA Excellence Awards finalists announced